ACR Updates Guideline for Medication Management in Hip or Knee Arthroplasty
HCP Live reports the American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) published an updated version of the guideline for perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or knee arthroplasty.
Susan M. Goodman, MD, rheumatologist at HSS and co-principal investigator of the guideline, said, “Patients with rheumatic diseases such as rheumatoid arthritis or psoriatic arthritis are at a much higher risk for adverse events, particularly infections, after total hip and total knee replacement.”
“Some risk factors for infection, such as disease severity or overall disability, are not modifiable,” she noted, “but immunosuppressing medications used to treat rheumatic musculoskeletal diseases are an accessible target where perioperative management may decrease risk.”
Read the full article at Hcplive.com.
Additional coverage:
